We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Following weeks of speculation, Johnson & Johnson (J&J) finally hammered out a deal Dec. 16 to purchase medical device giant Guidant, giving the company its first foothold in the rapidly growing cardiac rhythm device market.